Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1591, 2007-01, pp. : 19-19
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
RECORD trial: no definitive conclusions reached for rosiglitazone
Reactions Weekly, Vol. 1, Iss. 1256, 2009-01 ,pp. :
Access to resources
Recommend
The sweet and sour RECORD of rosiglitazone for type 2 diabetes
Reactions Weekly, Vol. 1, Iss. 1155, 2007-01 ,pp. :
By Wolffenbuttel B.H. Sels J-P. Huijberts M.S.
Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. :
By Barman Balfour J.A. Plosker G.L.
Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. :
Guilty plea and record $3 billion fine for GSK in US
Reactions Weekly, Vol. 1, Iss. 1410, 2012-01 ,pp. :